Tax withholding trims Inspire Medical (NASDAQ: INSP) officer’s shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Inspire Medical Systems officer Carlton Weatherby, Chief Strategy and Growth Officer, reported a tax-withholding disposition of 327 shares of common stock on February 9, 2026 at $66.33 per share. After this transaction, Weatherby directly owned 7,130 shares of Inspire Medical Systems common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Weatherby Carlton
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 327 | $66.33 | $22K |
Holdings After Transaction:
Common Stock — 7,130 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did INSP officer Carlton Weatherby report?
Carlton Weatherby reported a tax-withholding disposition of 327 shares of Inspire Medical Systems common stock. The shares were withheld by the company to satisfy taxes due on the vesting of a restricted stock unit award on February 9, 2026.
Was the INSP insider transaction an open market sale or tax withholding?
The transaction was a tax-withholding disposition, not an open market sale. Shares were withheld by Inspire Medical Systems to cover taxes triggered by the vesting of a restricted stock unit award, as explained in the footnote to the Form 4 filing.
What is Carlton Weatherby’s role at Inspire Medical Systems (INSP)?
Carlton Weatherby serves as Chief Strategy and Growth Officer at Inspire Medical Systems. His role is disclosed in the Form 4 remarks section, which also identifies him as an officer of the company involved in the reported equity-based compensation transaction.
What does transaction code F mean in the INSP Form 4 filing?
Transaction code F indicates payment of a tax liability or exercise price by delivering or withholding securities. In this case, 327 shares of Inspire Medical Systems common stock were withheld to satisfy taxes from the vesting of a restricted stock unit award on February 9, 2026.